Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro.
Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. Blood. 2002 Jan 15; 99(2):664-71.
View in:
PubMed
subject areas
Adamantane
Apoptosis
Benzamides
Caspase 9
Caspases
Drug Synergism
Enzyme Induction
Enzyme Inhibitors
Fusion Proteins, bcr-abl
Humans
Hydroquinones
K562 Cells
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Phosphorylation
Piperazines
Protein Biosynthesis
Protein Processing, Post-Translational
Proteins
Pyrimidines
Recombinant Fusion Proteins
Serpins
Transfection
Tumor Cells, Cultured
Tumor Stem Cell Assay
Viral Proteins
X-Linked Inhibitor of Apoptosis Protein
authors with profiles
James Douglas Griffin, M.D.
Ellen L. Weisberg, Ph.D.